Masaki Yamamoto

Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia

Yasufumi Matsumura, Masaki Yamamoto, Miki Nagao et al. · Antimicrobial Agents and Chemotherapy · 2015 · 134 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Logistic Analysis +16

CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant <i>Escherichia coli</i> of the <i>H</i> 30 subclonal group within ST131 drive a Japanese regional ESBL epidemic

Yasufumi Matsumura, James R. Johnson, Masaki Yamamoto et al. · Journal of Antimicrobial Chemotherapy · 2015 · 126 citations · Full text

Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes

Yasufumi Matsumura, Yuichiro Shindo, Yoshitsugu Iinuma et al. · BMC Infectious Diseases · 2011 · 108 citations · Full text

Rapid Identification of Different Escherichia coli Sequence Type 131 Clades

Yasufumi Matsumura, Johann Pitout, Gisele Peirano et al. · Antimicrobial Agents and Chemotherapy · 2017 · 101 citations · Full text

Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012–2014

Satoshi Nakano, Takao Fujisawa, Yutaka Ito et al. · Vaccine · 2015 · 99 citations · Full text

Molecular Epidemiology, Klebsiella Pneumoniae, Ipd Isolates +18